# PDGFD: A Dual-Function Regulator That Maintains Myoblast Pool and Fuels Myogenic Differentiation

**Authors:** Hongzhen Cao, Jing Wang, Yunzhou Wang, Jingsen Huang, Wei Chen, Hui Tang, Junfeng Chen, Baosong Xing, Yongqing Zeng

PMC · DOI: 10.3390/cimb48030322 · 2026-03-18

## TL;DR

This study discovers that PDGFD helps maintain muscle cell populations and promotes muscle cell differentiation in skeletal muscle development.

## Contribution

The novel dual role of PDGFD in both maintaining myoblasts and initiating myogenic differentiation is identified for the first time.

## Key findings

- PDGFD knockdown inhibits myoblast proliferation and promotes apoptosis.
- PDGFD overexpression enhances cell viability and inhibits apoptosis.
- PDGFD regulates myogenic differentiation markers MyoD and MyoG.

## Abstract

The role of platelet-derived growth factor D (PDGFD) in mesenchymal cells is well-established, but its specific function in skeletal muscle generation remains unknown. This study reveals for the first time PDGFD’s dual regulatory role in myogenesis: it acts both as a “guardian” maintaining the myoblast pool and as an “initiator” driving myogenic differentiation. Through single-cell RNA sequencing analysis of skeletal muscle from Jiangquan Black pigs, we identified PDGFD as a common candidate gene for both muscle and fat development. In the C2C12 cell model, PDGFD knockdown significantly inhibited cell proliferation and promoted apoptosis, while overexpression enhanced viability and inhibited apoptosis, indicating its critical role in maintaining myoprogenic precursor cell homeostasis. Further studies revealed that PDGFD interference downregulated key myogenic differentiation markers MyoD and MyoG, inhibiting differentiation. Its expression peaked during mid-differentiation (D5), suggesting temporal regulation of differentiation. Interestingly, although PDGFD primarily acts through the PI3K/Akt pathway downstream of PDGFR-β, PDGFD knockdown did not show significant synergistic effects with PI3K/Akt pathway activation in inhibiting differentiation. This suggests PDGFD may specifically regulate myogenic differentiation via an independent or parallel signaling axis. This study not only expands the known functions of PDGFD in muscle biology but also provides new insights into the mechanisms by which growth factors coordinate cell fate decisions.

## Linked entities

- **Genes:** PDGFD (platelet derived growth factor D) [NCBI Gene 80310], MYOD1 (myogenic differentiation 1) [NCBI Gene 4654], MYOG (myogenin) [NCBI Gene 4656], PDGFRB (platelet derived growth factor receptor beta) [NCBI Gene 5159]

## Full-text entities

- **Genes:** PDGFB (platelet derived growth factor subunit B) [NCBI Gene 100626465] {aka PDGF-2}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 100126861] {aka Akt, PKB}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Pdgfra (platelet derived growth factor receptor, alpha polypeptide) [NCBI Gene 18595] {aka CD140a, Pdgfr-2}, PDGFD (platelet derived growth factor D) [NCBI Gene 100524161], Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Anxa5 (annexin A5) [NCBI Gene 11747] {aka Anx5, CPB-I}, MYOG (myogenin) [NCBI Gene 497618], Pdgfd (platelet-derived growth factor, D polypeptide) [NCBI Gene 71785] {aka 1110003I09Rik}, Mef2c (myocyte enhancer factor 2C) [NCBI Gene 17260] {aka 5430401D19Rik, 9930028G15Rik, Mef2}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, MYOD1 (myogenic differentiation 1) [NCBI Gene 407604] {aka MUF3, MYF-3, MYOD}, Pdgfc (platelet-derived growth factor, C polypeptide) [NCBI Gene 54635] {aka 1110064L01Rik, PDGF-C, SCDGF, VEGF-E}, Myod1 (myogenic differentiation 1) [NCBI Gene 17927] {aka MYF3, MyoD, Myod-1, bHLHc1}, Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}, Myog (myogenin) [NCBI Gene 17928] {aka MYF4, bHLHc3, myo}, PDGFA [NCBI Gene 100126841], Ephb2 (Eph receptor B2) [NCBI Gene 13844] {aka Cek5, Drt, ETECK, Erk, Hek5, Nuk}, PDGFR-beta [NCBI Gene 100126842]
- **Diseases:** inflammation (MESH:D007249), fibrosis (MESH:D005355), infection (MESH:D007239), injury to (MESH:D014947), tumorigenesis (MESH:D063646)
- **Chemicals:** CO2 (MESH:D002245), kanamycin (MESH:D007612), gentamycin (MESH:D005839), water (MESH:D014867), PI (MESH:D010716), PBS (MESH:D007854), penicillin (MESH:D010406), DMSO (MESH:D004121), CCK-8 (MESH:D012844), paraformaldehyde (MESH:C003043), SDS (MESH:D012967), DAPI (MESH:C007293), Alexa Fluor 647 (MESH:C569686), EdU-488 (-), PVDF (MESH:C024865), HS (MESH:D006859), streptomycin (MESH:D013307), Edu (MESH:C022811), Triton X-100 (MESH:D017830)
- **Species:** Sus scrofa (pig, species) [taxon 9823], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** C1062M
- **Cell lines:** C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13025337/full.md

---
Source: https://tomesphere.com/paper/PMC13025337